Showing results (261-270 of 337) with videos related to
Sort By:
Pageof 34
American Journal of Human Genetics|January 1, 1997
Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6M Delépine, F Pociot, C Habita, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2013
Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicinManthena V S Varma, Jian Lin, Yi-An Bi, et al.Optics Express|November 23, 2021
Mid-infrared interband cascade light emitting devices grown on off-axis silicon substratesChadwick L Canedy, William W Bewley, Stephanie Tomasulo, et al.Molecular Pharmaceutics|April 12, 2012
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discoveryManthena V Varma, Iain Gardner, Stefanus J Steyn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphomaMark Kirschbaum, Paul Frankel, Leslie Popplewell, et al.Plos One|February 11, 2022
Limited reciprocal surrogacy of bird and habitat diversity and inconsistencies in their representation in Romanian protected areasJulia C Geue, Paula J Rotter, Caspar Gross, et al.The Oncologist|December 11, 2014
Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional ageArti Hurria, M Suzette Blanchard, Timothy W Synold, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 2, 2013
Elucidation of the biochemical basis for a clinical drug-drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778875), a subtype selective agonist of the peroxisome proliferator-activated receptor alphaAmit S Kalgutkar, Danny Chen, Manthena V Varma, et al.Angewandte Chemie (International Ed. in English)|September 16, 2014
Improving on nature: making a cyclic heptapeptide orally bioavailableDaniel S Nielsen, Huy N Hoang, Rink-Jan Lohman, et al.Journal of Medicinal Chemistry|February 21, 2022
N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-LactamasesCansu Kaya, Jelena Konstantinović, Andreas M Kany, et al.Pageof 34